Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.44% inched 0.01% higher to $172.20 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.08% falling 0.54% to 4,395.26 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.15% falling 0.42% to 34,935.47. Johnson & Johnson closed $1.45 short of its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.14% rose 1.79% to $389.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.06% fell 0.08% to $76.87, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.63% rose 0.05% to $42.81. Trading volume (5.3 M) remained 1.0 million below its 50-day average volume of 6.4 M.